VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
AMRZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AMRZAmrize Ltd
$46.69$25.8B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMRZBalance Sheet

Amrize Ltd (AMRZ) Balance Sheet

4Y historyFree accessUpdated daily

Leverage has improved markedly, with total debt down from $10.2B to $6.6B and D/E halved to 0.52, but the current ratio has tightened to 1.10 and goodwill of $9.0B (37% of assets) remains an overhang.

AMRZ Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets4.28B4.68B4.49B3.94B3.16B
Cash & Short-Term Investments1.1B1.92B1.82B1.11B351M
Cash Only1.1B1.92B1.82B1.11B351M
Short-Term Investments00000
Accounts Receivable1.36B1.12B1.07B1.4B1.41B
Days Sales Outstanding49.1534.633.3443.747.98
Inventory1.57B1.55B1.45B1.31B1.23B
Days Inventory Outstanding64.3664.4761.3853.5554.3
Other Current Assets260M88M144M40M51M
Total Non-Current Assets19.98B19.57B19.03B19.11B17.51B
Property, Plant & Equipment8.97B8.54B8.08B8.07B7.75B
Fixed Asset Turnover1.39x1.38x1.45x1.45x1.38x
Goodwill9.07B9.02B8.92B8.97B8.12B
Intangible Assets1.7B1.73B1.83B1.88B1.44B
Long-Term Investments50M056M63M0
Other Non-Current Assets242M277M198M121M202M
Total Assets24.27B24.25B23.52B23.05B20.67B
Asset Turnover0.49x0.49x0.50x0.51x0.52x
Asset Growth %12.03%3.11%2.04%11.5%-
Total Current Liabilities3.05B2.86B2.43B2.44B2.25B
Accounts Payable1.02B1.54B1.37B1.25B1.14B
Days Payables Outstanding53.7563.9358.0951.1450.59
Short-Term Debt1.24B333M5M131M348M
Deferred Revenue (Current)38M0048M43M
Other Current Liabilities792M850M902M532M464M
Current Ratio1.40x1.64x1.85x1.61x1.40x
Quick Ratio0.89x1.10x1.25x1.08x0.86x
Cash Conversion Cycle59.7635.1436.6446.1251.7
Total Non-Current Liabilities8.13B8.14B7.78B11.4B10.21B
Long-Term Debt4.94B4.94B4.94B8.64B7.62B
Capital Lease Obligations2.58B500M698M564M516M
Deferred Tax Liabilities2.98B0937M998M944M
Other Non-Current Liabilities1.59B2.7B868M930M873M
Total Liabilities11.18B10.99B10.21B13.84B12.46B
Total Debt6.67B5.91B5.79B9.52B8.66B
Net Debt5.57B3.98B3.96B8.42B8.31B
Debt / Equity0.51x0.45x0.43x1.03x1.05x
Debt / EBITDA2.42x2.10x1.89x3.48x3.48x
Net Debt / EBITDA2.02x1.42x1.29x3.07x3.34x
Interest Coverage5.07x4.62x7.03x3.37x6.89x
Total Equity13.09B13.25B13.31B9.2B8.21B
Equity Growth %36.11%-0.4%44.59%12.1%-
Book Value per Share23.6623.9424.0516.6514.85
Total Shareholders' Equity13.09B13.25B13.31B9.2B8.21B
Common Stock013.25B6M00
Retained Earnings00000
Treasury Stock00000
Accumulated OCI00-604M-317M-372M
Minority Interest00-1M01M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Goodwill impairment risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Reduction and Cash Build

AMRZ's balance sheet strengthened markedly over the past year, with total debt down from $9.5B to $6.6B and cash up from $1.1B to $729M, per quarterly filings, signaling improved financial flexibility.

The sequential decline in total liabilities from $14.2B in 2024Q3 to $11.7B in 2026Q2, alongside a reduction in debt from $10.2B to $6.6B, indicates a deliberate deleveraging trend. This is reinforced by a D/E ratio that fell from 1.04 to 0.52, suggesting the company is prioritizing balance sheet strength. The cash position, while lower than the $1.9B peak in 2025Q4, remains adequate given the reduced debt load, and the trajectory implies a more resilient capital structure.

Deleveraging with Strategic Debt Reduction

Total debt dropped from $10.2B in 2024Q3 to $6.6B in 2026Q2, cutting the D/E ratio from 1.04 to 0.52, as reported in financial statements, indicating a strategic shift toward lower leverage.

The debt reduction appears deliberate, as the company has used cash flows to pay down obligations, with debt-to-assets falling from 0.43 to 0.27 over the same period. This lower leverage provides a buffer against cyclical downturns in construction, a key risk given the industry's sensitivity to interest rates. The current D/E of 0.52 is below peers like VMC (0.63) and MLM (0.53), suggesting AMRZ has greater financial flexibility to weather a downturn or pursue growth opportunities.

Asset Mix Reflects Heavy Investment

PP&E net rose from $8.1B to $9.1B over the past year, while goodwill remained stable at $9.0B, per balance sheet data, indicating continued capital investment in fixed assets.

The increase in PP&E suggests ongoing investment in capacity to support mega-project demand, consistent with the capex trends noted in the cash flow analysis. However, goodwill of $9.0B represents 37% of total assets, a significant portion that could be at risk if the Solutions & Products segment underperforms. The stable goodwill level suggests no impairments have been taken, but investors should monitor this given the cyclicality of construction markets.

Equity Quality Supported by Retained Earnings

Equity grew from $9.2B in 2023Q4 to $12.9B in 2026Q2, with retained earnings turning positive in 2025Q3, as per quarterly data, indicating improving internal capital generation.

The rise in equity is driven by retained earnings, which swung from zero to $601M in 2025Q3, reflecting profitable operations. This improvement in equity quality reduces reliance on external financing and supports the company's ability to fund dividends and buybacks, as seen in Q2 2026. The positive retained earnings also suggest that the spin-off has not eroded the equity base, and the company is building a cushion for future investments.

Liquidity Buffer Adequate but Tightening

Current ratio fell from 1.85 in 2024Q4 to 1.10 in 2026Q2, while cash dropped from $1.8B to $729M, as reported in balance sheet data, indicating a thinner short-term buffer.

The decline in the current ratio suggests that current liabilities have grown relative to current assets, possibly due to increased payables or short-term debt. However, with $729M in cash and a low debt load, the company likely has sufficient liquidity to meet near-term obligations. The cash position is lower than the $1.9B peak, but the reduced debt service requirements partially offset this, and the strong operating cash flow in Q2 2026 provides additional support.

Goodwill and Intangibles Overhang

Goodwill of $9.0B, representing 37% of total assets, remains a significant balance sheet risk, as per reported figures, and could be impaired if the Solutions & Products segment underperforms.

The large goodwill balance, likely from acquisitions like Firestone and Malarkey, exposes AMRZ to impairment risk if growth in those segments falters. While no impairments have been recorded to date, the cyclical nature of construction and potential regulatory changes could pressure valuations. Investors should monitor segment performance and any changes in discount rates or cash flow projections that could trigger an impairment charge, which would directly reduce equity.

AMRZ — Frequently Asked Questions

Quick answers to the most common questions about buying AMRZ stock.

What are the total assets of Amrize Ltd (AMRZ)?

As of 2025, Amrize Ltd (AMRZ) had total assets of $24.25B including $4.68B in current assets.

How much debt does Amrize Ltd (AMRZ) have?

Amrize Ltd (AMRZ) carries total debt of $5.91B, offset by $1.92B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Amrize Ltd?

Amrize Ltd (AMRZ) has total shareholders' equity (book value) of $13.25B ($23.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Amrize Ltd's current ratio and liquidity?

Amrize Ltd (AMRZ) reported a current ratio of 1.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.